Article: A Rapid, Low-Risk Approach for Process Transfer of Biologics From Development to Manufacturing Scale

This article published in BioProcess International describes a scale-up approach that enables faster and more cost-effective manufacture of biologics in fed-batch cultures. It highlights a scaling methodology with a range of single-use bioreactors (15mL to 200L) from process development with Ambr® bioreactors, through to pilot & manufacturing with Biostat® STR bioreactors.

Complete Form to Access the File